These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 30647492)
1. Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel. Izawa Y; Kashii-Magaribuchi K; Yoshida K; Nosaka M; Tsuji N; Yamamoto A; Kuroyanagi K; Tono K; Tanihata M; Imanishi M; Onishi M; Sakiyama M; Inoue S; Takahashi R Acta Histochem Cytochem; 2018 Dec; 51(6):173-183. PubMed ID: 30647492 [TBL] [Abstract][Full Text] [Related]
2. Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer. Sun H; Yao N; Cheng S; Li L; Liu S; Yang Z; Shang G; Zhang D; Yao Z Cancer Biol Med; 2019 May; 16(2):299-311. PubMed ID: 31516750 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells. Aikins AR; Kim M; Raymundo B; Kim CW Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861 [TBL] [Abstract][Full Text] [Related]
4. Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells. Maiti A; Qi Q; Peng X; Yan L; Takabe K; Hait NC Int J Oncol; 2019 Jul; 55(1):116-130. PubMed ID: 31059004 [TBL] [Abstract][Full Text] [Related]
5. Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells. Liu Y; Sun B; Liu T; Zhao X; Wang X; Li Y; Meng J; Gu Q; Liu F; Dong X; Liu P; Sun R; Zhao N Onco Targets Ther; 2016; 9():3473-84. PubMed ID: 27366084 [TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor/heat shock protein 27 pathway regulates vasculogenic mimicry activity of breast cancer stem/progenitor cells. Lee CH; Wu YT; Hsieh HC; Yu Y; Yu AL; Chang WW Biochimie; 2014 Sep; 104():117-26. PubMed ID: 24950183 [TBL] [Abstract][Full Text] [Related]
7. An Overview of Vasculogenic Mimicry in Breast Cancer. Andonegui-Elguera MA; Alfaro-Mora Y; Cáceres-Gutiérrez R; Caro-Sánchez CHS; Herrera LA; Díaz-Chávez J Front Oncol; 2020; 10():220. PubMed ID: 32175277 [TBL] [Abstract][Full Text] [Related]
8. Epithelial cell adhesion molecule and epithelial-mesenchymal transition are associated with vasculogenic mimicry, poor prognosis, and metastasis of triple negative breast cancer. Wu Q; Wang J; Liu Y; Gong X Int J Clin Exp Pathol; 2019; 12(5):1678-1689. PubMed ID: 31933986 [TBL] [Abstract][Full Text] [Related]
9. Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway. Hsu JL; Leu WJ; Hsu LC; Hsieh CH; Guh JH Oncol Lett; 2024 Apr; 27(4):170. PubMed ID: 38455663 [TBL] [Abstract][Full Text] [Related]
10. Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells. Haiaty S; Rashidi MR; Akbarzadeh M; Bazmani A; Mostafazadeh M; Nikanfar S; Zibaei Z; Rahbarghazi R; Nouri M BMC Complement Med Ther; 2021 Mar; 21(1):83. PubMed ID: 33663486 [TBL] [Abstract][Full Text] [Related]
11. New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells. Charfi C; Demeule M; Currie JC; Larocque A; Zgheib A; Danalache BA; Ouanouki A; Béliveau R; Marsolais C; Annabi B Front Oncol; 2021; 11():760787. PubMed ID: 34751242 [TBL] [Abstract][Full Text] [Related]
12. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer. Liu TJ; Sun BC; Zhao XL; Zhao XM; Sun T; Gu Q; Yao Z; Dong XY; Zhao N; Liu N Oncogene; 2013 Jan; 32(5):544-53. PubMed ID: 22469978 [TBL] [Abstract][Full Text] [Related]
13. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line. Maroufi NF; Rashidi M; Vahedian V; Jahanbazi R; Mostafaei S; Akbarzadeh M; Kazemzadeh H; Nejabati HR; Isazadeh A; Rashidi MR; Nouri M Breast Cancer; 2022 Mar; 29(2):260-273. PubMed ID: 34725795 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer. Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325 [TBL] [Abstract][Full Text] [Related]
15. USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry. Liu T; Sun B; Zhao X; Li Y; Zhao X; Liu Y; Yao Z; Gu Q; Dong X; Shao B; Lin X; Liu F; An J Mol Cancer Ther; 2015 Sep; 14(9):2121-31. PubMed ID: 26232424 [TBL] [Abstract][Full Text] [Related]
16. The effect of interleukin-17F on vasculogenic mimicry in oral tongue squamous cell carcinoma. Almahmoudi R; Salem A; Hadler-Olsen E; Svineng G; Salo T; Al-Samadi A Cancer Sci; 2021 Jun; 112(6):2223-2232. PubMed ID: 33743555 [TBL] [Abstract][Full Text] [Related]
17. Antibody-Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling. Sankar AP; Cho HM; Shin SU; Sneh T; Ramakrishnan S; Elledge C; Zhang Y; Das R; Gil-Henn H; Rosenblatt JD Cancer Res Commun; 2024 Mar; 4(3):738-756. PubMed ID: 38315147 [TBL] [Abstract][Full Text] [Related]
18. IL-1β Promotes Vasculogenic Mimicry of Breast Cancer Cells Through p38/MAPK and PI3K/Akt Signaling Pathways. Nisar MA; Zheng Q; Saleem MZ; Ahmmed B; Ramzan MN; Ud Din SR; Tahir N; Liu S; Yan Q Front Oncol; 2021; 11():618839. PubMed ID: 34055597 [TBL] [Abstract][Full Text] [Related]
19. Effect of grape seed proanthocyanidins on tumor vasculogenic mimicry in human triple-negative breast cancer cells. Luan YY; Liu ZM; Zhong JY; Yao RY; Yu HS Asian Pac J Cancer Prev; 2015; 16(2):531-5. PubMed ID: 25684483 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-204 Regulates Angiogenesis and Vasculogenic Mimicry in CD44+/CD24- Breast Cancer Stem-like Cells. Resendiz-Hernández M; García-Hernández AP; Silva-Cázares MB; Coronado-Uribe R; Hernández-de la Cruz ON; Arriaga-Pizano LA; Prieto-Chávez JL; Salinas-Vera YM; Ibarra-Sierra E; Ortiz-Martínez C; López-Camarillo C Noncoding RNA; 2024 Feb; 10(1):. PubMed ID: 38392969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]